COST

1,009.37

+1.41%↑

PG

161.54

+1.96%↑

KO

71.2

+2.93%↑

PM

168.24

+2.65%↑

PEP

130.83

+1.73%↑

COST

1,009.37

+1.41%↑

PG

161.54

+1.96%↑

KO

71.2

+2.93%↑

PM

168.24

+2.65%↑

PEP

130.83

+1.73%↑

COST

1,009.37

+1.41%↑

PG

161.54

+1.96%↑

KO

71.2

+2.93%↑

PM

168.24

+2.65%↑

PEP

130.83

+1.73%↑

COST

1,009.37

+1.41%↑

PG

161.54

+1.96%↑

KO

71.2

+2.93%↑

PM

168.24

+2.65%↑

PEP

130.83

+1.73%↑

COST

1,009.37

+1.41%↑

PG

161.54

+1.96%↑

KO

71.2

+2.93%↑

PM

168.24

+2.65%↑

PEP

130.83

+1.73%↑

Search

USANA Health Sciences Inc

Open

29.74 2.27

Overview

Share price change

24h

Current

Min

28.6

Max

29.91

Key metrics

By Trading Economics

Income

4.8M

9.3M

Sales

36M

250M

P/E

Sector Avg

16.495

42.52

EPS

0.73

Profit margin

3.723

Employees

1,700

EBITDA

11M

27M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+72.89% upside

Dividends

By Dow Jones

Next Earnings

22 lip 2025

Market Stats

By TradingEconomics

Market Cap

40M

559M

Previous open

27.47

Previous close

29.74

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

USANA Health Sciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 maj 2025, 23:40 UTC

Hot Stocks

Stocks to Watch: UnitedHealth Group, Foot Locker, CoreWeave

14 maj 2025, 23:33 UTC

Major Market Movers

UnitedHealth Group Shares Fall After WSJ Reports of Investigation for Possible Medicare Fraud

14 maj 2025, 23:25 UTC

Major Market Movers

Biohaven Shares Down as FDA Extends PDUFA Data for Troriluzole

14 maj 2025, 23:25 UTC

Earnings

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth -- Update

14 maj 2025, 22:58 UTC

Earnings

Xero Lifts Fiscal Year Profit 30% on Higher Prices, Subscriber Growth

14 maj 2025, 21:35 UTC

Earnings

Cisco Systems Names Patterson as CFO, Patel as President

14 maj 2025, 23:59 UTC

Market Talk

Implications of Xero's Cost Outlook Aren't Clear -- Market Talk

14 maj 2025, 23:49 UTC

Market Talk

Xero's Cost Outlook Likely to Prompt Downgrades -- Market Talk

14 maj 2025, 23:48 UTC

Market Talk

Global Equities Roundup: Market Talk

14 maj 2025, 23:48 UTC

Market Talk

Nikkei May Decline on Profit-Taking After Recent Gains -- Market Talk

14 maj 2025, 23:47 UTC

Market Talk

Gold Gains on Possible Technical Recovery -- Market Talk

14 maj 2025, 23:34 UTC

Acquisitions, Mergers, Takeovers

Agnico-Eagle Mines to Subscribe for 30M Voting Common Shares of Foran Mining in Non-Brokered Private Placement at C$3 a Share

14 maj 2025, 23:10 UTC

Earnings

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth -- Update

14 maj 2025, 23:07 UTC

Earnings

CoreWeave Posts Strong Revenue and Wins Google as a Customer. Stock Still Dives on Outlook. -- Barrons.com

14 maj 2025, 23:00 UTC

Top News

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud -- WSJ

14 maj 2025, 22:43 UTC

Earnings

Xero Lifts FY Profit 30% on Higher Prices, Subscriber Growth

14 maj 2025, 22:34 UTC

Earnings

Xero Expects 1H Operating Expense Ratio to Be Higher Than 2H>XRO.AU

14 maj 2025, 22:33 UTC

Earnings

Xero Expects FY26 Operating Expense Ratio of 71.5%>XRO.AU

14 maj 2025, 22:30 UTC

Earnings

Xero Did Not Declare a Dividend>XRO.AU

14 maj 2025, 22:30 UTC

Earnings

Xero FY Operating Expenses 71.8% of Operating Revenue Vs. 73.3%>XRO.AU

14 maj 2025, 22:30 UTC

Earnings

Xero FY Free Cashflow Margin 24.1% Vs. 20.0%>XRO.AU

14 maj 2025, 22:30 UTC

Earnings

Xero FY Free Cashflow NZD506.7M Vs. NZD342.1M>XRO.AU

14 maj 2025, 22:28 UTC

Earnings

Xero FY Ebitda NZD638.5M Vs. NZD497.4M>XRO.AU

14 maj 2025, 22:28 UTC

Earnings

Xero FY Adjusted Ebitda NZD640.6M Vs. NZD526.5M>XRO.AU

14 maj 2025, 22:27 UTC

Earnings

Xero FY Rev NZD2.10B Vs. NZD1.71B >XRO.AU

14 maj 2025, 22:27 UTC

Earnings

Xero FY Net NZD227.8M Vs. Net NZD174.6M >XRO.AU

14 maj 2025, 22:23 UTC

Top News

Boeing, GE Aerospace Get Qatar Airways Order After Saudi AI Tech Deals -- 2nd Update

14 maj 2025, 22:15 UTC

Earnings

Correction to Cisco Earnings Article -- WSJ

14 maj 2025, 21:48 UTC

Earnings

CoreWeave Posts Strong Revenue but Stock Dives on Updated Outlook -- Barrons.com

14 maj 2025, 21:37 UTC

Earnings

Cisco Reports Solid Earnings. The Stock Is Rising. -- Barrons.com

Peer Comparison

Price change

USANA Health Sciences Inc Forecast

Price Target

By TipRanks

72.89% upside

12 Months Forecast

Average 50.5 USD  72.89%

High 65 USD

Low 36 USD

Based on 2 Wall Street analysts offering 12 month price targets forUSANA Health Sciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

2 ratings

0

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

28.405 / 29.84Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.